2022 NICE 技术评估指南:乌帕替尼治疗活动期强直性脊柱炎 [TA829]

2022-09-30 英国国家卫生与临床优化研究所 NICE官网

关于乌帕替尼(Rinvoq) 用于治疗成人常规治疗不能很好控制的活动期强直性脊柱炎的循证建议。

中文标题:

2022 NICE 技术评估指南:乌帕替尼治疗活动期强直性脊柱炎 [TA829]

英文标题:

Upadacitinib for treating active ankylosing spondylitis Technology appraisal guidance [TA829]

发布日期:

2022-09-30

简要介绍:

关于乌帕替尼(Rinvoq) 用于治疗成人常规治疗不能很好控制的活动期强直性脊柱炎的循证建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2022 NICE 技术评估指南:乌帕替尼治疗活动性强直性脊柱炎 [TA829].pdf)] GetToolGuiderByIdResponse(projectId=1, id=027d81c002e01a09, title=2022 NICE 技术评估指南:乌帕替尼治疗活动期强直性脊柱炎 [TA829], enTitle=Upadacitinib for treating active ankylosing spondylitis Technology appraisal guidance [TA829], guiderFrom=NICE官网, authorId=0, author=, summary=关于乌帕替尼(Rinvoq) 用于治疗成人常规治疗不能很好控制的活动期强直性脊柱炎的循证建议。, cover=https://img.medsci.cn/20220930/1664503447975_5579292.png, journalId=0, articlesId=null, associationId=2005, associationName=英国国家卫生与临床优化研究所 , associationIntro=英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence), copyright=0, guiderPublishedTime=Fri Sep 30 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #000000;">关于乌帕替尼(Rinvoq) 用于治疗成人常规治疗不能很好控制的活动期强直性脊柱炎的循证建议。</span></p>, tagList=[TagDto(tagId=31494, tagName=活动期强直性脊柱炎), TagDto(tagId=69241, tagName=乌帕替尼)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2589, appHits=44, showAppHits=0, pcHits=201, showPcHits=2545, likes=0, shares=5, comments=1, approvalStatus=1, publishedTime=Sat Oct 08 21:00:00 CST 2022, publishedTimeString=2022-09-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=7, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Sep 30 10:04:14 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 15:32:25 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 NICE 技术评估指南:乌帕替尼治疗活动性强直性脊柱炎 [TA829].pdf)])
2022 NICE 技术评估指南:乌帕替尼治疗活动性强直性脊柱炎 [TA829].pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2092596, encodeId=e019209259650, content=了解了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ad56519030, createdName=ms6000001326265410, createdTime=Sun Oct 09 00:09:45 CST 2022, time=2022-10-09, status=1, ipAttribution=)]
    2022-10-09 ms6000001326265410

    了解了

    0